This contract expires in 301 days (Aug 23, 2027).
YALE UNIV - ROLE OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS VERSUS DPP-4 INHIBITORS FOR ALCOHOL AND SUBSTANCE USE DISORDERS IN IMPROVING HIV-RELATED OUTCOMES AND PROVIDING HEALTH BENEFITS IN PEOPLE LIVING WITH HIV
Key Details
Description
ROLE OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS VERSUS DPP-4 INHIBITORS FOR ALCOHOL AND SUBSTANCE USE DISORDERS IN IMPROVING HIV-RELATED OUTCOMES AND PROVIDING HEALTH BENEFITS IN PEOPLE LIVING WITH HIV
Context & Analysis
On Aug 18, 2026, Department of Health and Human Services obligated $251,751.97 to YALE UNIV for role of glucagon-like peptide-1 (glp-1) receptor agonists versus dpp-4 inhibitors for alcohol and substance use disorders in improving hiv-related outcomes and providing health benefits in people livi…. The award is classified under NAICS 541690 — OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES. Competition extent: competed under sap with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in NEW HAVEN, CT. The contract is scheduled through Aug 23, 2027 — approximately 10 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541690 — related awards are listed below.
Contractor Information
Related Federal Investment
Similar Awards
IGF::OT::IGF SAMHSA'S PERFORMANCE ACCOUNTABILITY AND REPORTING SYSTEM (SPARS)
RESEARCH TRIANGLE INSTITUTE
$41.8M
HEALTHCARE COST AND UTILIZATION PROJECT (HCUP) CLIN 0002 BASE AWARD
NATIONAL OPINION RESEARCH CENTER
$33.7M
HEALTHCARE COST AND UTILIZATION PROJECT (HCUP) CLIN 0002 BASE AWARD
NATIONAL OPINION RESEARCH CENTER
$33.7M
SENTINEL 2.0 BRIDGE CONTRACT
HARVARD PILGRIM HEALTH CARE, INC.
$32.9M
MIDS DEVELOPMENT, REEVALUATION AND IMPLEMENTATION OF OUTCOME/EFFICIENCY MEASURES FOR HOSPITAL AND ELIGIBLE CLINICIANS
YALE NEW HAVEN HEALTH SERVICES CORPORATION
$31.1M
Stay Updated
Get notified about new opportunities matching your interests.